Time on boards
- Boards served
- 2
- Current seats
- 2
- Board service
- 6 years
- Director since
- 2023
6 years of board service in total across 2 boards, counting each seat separately. Longest: Arrowhead Pharmaceuticals Inc., 3 years.
Arrowhead Pharmaceuticals Inc.
Director
Vir Biotechnology Inc.
Director · President and CEO
Chief executive roles
Vir Biotechnology Inc.
· Chief Executive Officer
Dates unknown
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
| Date | Company | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Apr 29, 2026 | Vir Biotechnology Inc. | Other | −233,532 | — | — |
| Apr 29, 2026 | Vir Biotechnology Inc. | Other | +233,532 | — | — |
| Apr 6, 2026 | Vir Biotechnology Inc. | Open-market sale | −72,559 | $9.16 | $664,640 |
| Feb 24, 2026 | Vir Biotechnology Inc. | Open-market sale | −14,762 | $9.53 | $140,682 |
| Feb 23, 2026 | Vir Biotechnology Inc. | Open-market sale | −19,039 | $7.45 | $141,841 |
| Feb 22, 2026 | Vir Biotechnology Inc. | Grant or award | +285,000 | — | — |
| Apr 3, 2025 | Vir Biotechnology Inc. | Open-market sale | −79,712 | $5.95 | $474,286 |
| Feb 24, 2025 | Vir Biotechnology Inc. | Open-market sale | −16,122 | $9.45 | $152,353 |
| Feb 22, 2025 | Vir Biotechnology Inc. | Grant or award | +240,000 | — | — |
| Jun 12, 2024 | Vir Biotechnology Inc. | Other | −53,118 | — | — |
| Jun 12, 2024 | Vir Biotechnology Inc. | Other | +53,118 | — | — |
| Apr 3, 2024 | Vir Biotechnology Inc. | Open-market sale | −72,995 | $9.46 | $690,533 |
| Feb 22, 2024 | Vir Biotechnology Inc. | Grant or award | +175,000 | — | — |
| Apr 3, 2023 | Vir Biotechnology Inc. | Grant or award | +576,452 | — | — |
| Jan 10, 2023 | Arrowhead Pharmaceuticals Inc. | Grant or award | +7,867 | — | — |
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.